DAB.bio has successfully closed an investment round led by Navus Ventures to further develop its innovative FAST™ fermentation technology, aimed at revolutionizing industrial biomanufacturing.

Information on the Target

DAB.bio is an innovative technology company focused on industrial biomanufacturing, particularly through its proprietary FAST™ platform technology. This patented system continuously extracts products from fermenters while maintaining microbial biomass, thus enhancing productivity and efficiency. By circumventing the need for costly membranes, centrifuges, or external loops, DAB.bio's FAST™ technology significantly reduces capital expenditure (capex), thereby presenting a disruptive solution for large-scale biomanufacturing, particularly in the competitive sectors of chemicals, fuels, and proteins derived from renewable sources.

Founded with the vision of facilitating the transition to a renewable carbon economy, DAB.bio's technological advancements aim to mitigate the environmental impacts commonly associated with traditional manufacturing processes in the chemical and food/feed industries. The firm has made substantial progress, evidenced by its initial commercial successes, and is now poised to expand further with the backing of its investors.

Industry Overview in the Target’s Specific Country

The industrial biotechnology sector in the Netherlands is burgeoning, driven by increasing demands for sustainable production methods and renewable resources. Dutch policies and initiatives support innovation and sustainability within the biotech field, propelling investments an